← back to search

Riccardo Masina

University of Cambridge · GB
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer Genomics and Diagnostics, Bioinformatics and Genomic Networks, Computational Drug Discovery Methods, and Glioma Diagnosis and Treatment.
h-index
5
citations
167
works
28
NIH funding
primary concept
email

Recent publications

A large‐scale retrospective study in metastatic breast cancer patients using circulating tumour <scp>DNA</scp> and machine learning to predict treatment outcome and progression‐free survival
Molecular Oncology 2025cited by 5position: middledoi
Fitness and transcriptional plasticity of human breast cancer single-cell-derived clones
Cell Reports 2025cited by 4position: middledoi
Interventionally-guided representation learning for robust and interpretable AI models in cancer medicine
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 0position: middledoi
Surgery for pineal cysts with symptoms in the absence of hydrocephalus: a prospective cohort study
EClinicalMedicine 2025cited by 0position: firstdoi
Precision Cancer Medicine 2.0—Oncology in the postgenomic era
Molecular Oncology 2024cited by 6position: firstdoi
Modeling Drug Responses and Evolutionary Dynamics Using Patient-Derived Xenografts Reveals Precision Medicine Strategies for Triple-Negative Breast Cancer
Cancer Research 2024cited by 4position: middledoi
A large-scale retrospective study in metastatic breast cancer patients using circulating tumor DNA and machine learning to predict treatment outcome and progression-free survival
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 1position: middledoi
Modelling drug responses and evolutionary dynamics using triple negative breast cancer patient-derived xenografts
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 0position: middledoi
Tissue-Engineered Stromal Reticula to Study Lymph Node Fibroblastic Reticular Cells in Type I Diabetes
Cellular and Molecular Bioengineering 2020cited by 10position: middledoi
Circulating tumour DNA analysis using three next generation sequencing approaches in a phase 1b trial of ER positive metastatic breast cancer
European Journal of Cancer 2020cited by 0position: firstdoi
CCL21 Expression in β-Cells Induces Antigen-Expressing Stromal Cell Networks in the Pancreas and Prevents Autoimmune Diabetes in Mice
Diabetes 2019cited by 18position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Carlos Caldas · Concern Foundation5 papers (2020–2025)Oscar M. Rueda · University of Cambridge4 papers (2023–2025)Stephen‐John Sammut · Institute of Cancer Research4 papers (2023–2025)Meiling Gao · Hebei Medical University3 papers (2020–2025)Suet‐Feung Chin · Cancer Research UK Cambridge Center3 papers (2023–2025)Maurizio Callari · Fondazione Michelangelo3 papers (2020–2025)Davina Gale · AstraZeneca (United Kingdom)2 papers (2023–2025)Jonathan Lay · Cambridge University Hospitals NHS Foundation Trust2 papers (2023–2025)Mario Ortega-Duran · University of Cambridge2 papers (2023–2025)Ramona Woitek · Cambridge University Hospitals NHS Foundation Trust2 papers (2023–2025)Emma Beddowes · Cambridge University Hospitals NHS Foundation Trust2 papers (2023–2025)Anja Brouwer · University of Antwerp2 papers (2023–2025)James Tanner · Cambridge University Hospitals NHS Foundation Trust2 papers (2023–2025)Dana W.Y. Tsui · Memorial Sloan Kettering Cancer Center2 papers (2023–2025) · 2 papers (2023–2025) · 2 papers (2023–2025)Justine M. Kane · Cambridge University Hospitals NHS Foundation Trust2 papers (2023–2025)Alistair Martin · Cancer Research UK Cambridge Center2 papers (2023–2025)Alice A. Tomei · University of Miami2 papers (2019–2020)Nitzan Rosenfeld · Queen Elizabeth Hospital2 papers (2023–2025)